Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
6 participants
INTERVENTIONAL
2000-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methadone Versus Morphine for Cancer-Related Pain
NCT00573937
A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
NCT00929188
Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain
NCT00525967
Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain
NCT00101621
A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients
NCT00446069
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Metamizole - Diclofenac
metamizole followed by diclofenac
Metamizole
Diclofenac
Diclofenac placebo
Metamizole placebo
Diclofenac - Metamizole
diclofenac followed by metamizole
Metamizole
Diclofenac
Diclofenac placebo
Metamizole placebo
Metamizole - Placebo
metamizole followed by placebo
Metamizole
Diclofenac placebo
Metamizole placebo
Placebo - Metamizole
placebo followed by metamizole
Metamizole
Diclofenac placebo
Metamizole placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Metamizole
Diclofenac
Diclofenac placebo
Metamizole placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1093.14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.